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Abstract
Although it is well known that nasopharyngeal carcinoma (NPC) is closely relatedwith Epstein-Barr virus (EBV), few data
are available about which and how EBV-expressed gene is involved in the carcinogenesis of human nasopharyngeal
epithelial cells. EBV-encoded BARF1 (BamH I-A right frame 1) gene has been shown to be oncogenic and capable of
inducingmalignant transformation in BALB/c3T3 andNIH3T3 cells aswell as in humanB-cell lines Louckes and Akata. It
remains unclear, however, whether BARF1 can transform primate or human epithelial cells. Here, we have shown that
overexpression of H-Ras gene transformed BARF1-immortalized PATAS cells into malignant cell line. Furthermore,
we found that cooperation of BARF1 with H-Ras and SV40 T antigens was sufficient to transform nonmalignant
human nasopharyngeal epithelial NP69 cells when serially introduced BARF1 and H-Ras into the SV40 T antigens-
immortalized NP69 cells. Taken together, these results demonstrated that the cooperation of BARF1with Ras suffices
to transform primary primate epithelial cell PATAS. Similarly, BARF1 together with H-Ras and SV40 T can transform
human epithelial cell NP69, thereby indicating that BARF1 could be involved in the NPC pathogenesis in combination
with additional genetic changes.
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Introduction
Epstein-Barr virus (EBV) is a ubiquitous human γ herpes virus that
has infected more than 90% of the world’s adult population and has
closely been linked to the development of nasopharyngeal carcinoma
(NPC) [1–3]. However, despite the intensive studies of EBV for the
past years, the precise role of EBV infection in NPC carcinogenesis
remains poorly understood. EBV adopts a specific form of latent in-
fection, termed latency II, in NPC cells. EBV gene expression in this
state is usually limited to EBV-encoded RNA [4], nuclear antigen 1
(EBNA1) [5], latent membrane proteins 1 and 2 (LMP1 and LMP2)
[6,7], BamHI-A right frame 1 (BARF1), and several BamHI A tran-
scripts [8,9]. Among the EBV-encoded genes, LMP1 and BARF1 have
important effects on cellular gene expression [10] and may be involved
in EBV-mediated tumorigenesis.
LMP1 is considered an EBV oncogene because it can efficiently in-
duce anchorage-independent growth in the rodent fibroblast cell line
Rat-1 in vitro and tumor formation in nude mice in vivo [11,12]. How-
ever, LMP1 expression was detected in only approximately 50% of
EBV-positive NPC [13] and rarely in EBV-positive gastric cancers
[14]. In contrast, the expression of BARF1 was detected in up to 90%
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of cases of invasive NPC [15] and EBV-positive gastric cancers [16].
Another interesting observation is that, in primary primate kidney
epithelial cells immortalized by EBV infection, all cells expressed EBNA1
and BARF1 in the absence of detectable LMP1 or lytic proteins [17].
BARF1 has been shown to be able to induce malignant transfor-
mation in BALB/c3T3 and NIH3T3 cells as well as in human B-cell
lines Louckes and Akata [18–21]. In our previous study, we showed
that introduction of BARF1 gene into primary primate kidney epithe-
lial PATAS cells led to morphologic changes, continuous cell growth
(>100 passages) and the capacity to grow in highly diluted culture con-
dition. However, contact inhibition was conserved in these cells, and
no tumor formation was observed after injection into nude mice [22].
Thus, BARF1 by itself could only immortalize but could not transform
the primate primary epithelial cells. Meanwhile, the cellular function
of BARF1 in human nasopharyngeal epithelial cells, which are the
natural host cells of EBV infection, remains largely unknown because
of the lack of a suitable cell model. Therefore, whether BARF1 can
transform primate or human epithelial cells remains unclear.
In this study, to further explore the role of BARF1 in the patho-
genesis of NPC, we examined the transformation function of BARF1 in
both BARF1-immortalized primary primate kidney epithelial PATAS
cells and SV40 T antigens–immortalized nasopharyngeal epithelial
NP69 cells. Here, we showed that in cooperation with H-Ras gene,
BARF1 is able to induce malignant transformation of nontumorigenic
PATAS cells. Furthermore, we demonstrated here that the cooperation
of BARF1, SV40 T antigen (LT and ST), and H-Ras sufficed to trans-
form human nasopharyngeal epithelial NP69 cell and induce tumori-
genicity in nude mice.
Materials and Methods
Cell Culture
The PATAS, BARF1-transfected PATAS subclones [22], 293, 293T,
and HeLa cells were cultured in Dulbecco’s modified Eagle medium
(DMEM; Sigma, Lyon, France) supplemented with 10% fetal calf
serum, penicillin (120 μg/ml), and streptomycin (120 μg/ml) in a
5% CO2 incubator at 37°C. Tumor cell lines (LT1, LT2, and LT3)
were established from tumor induced by injection of P-BA-R cells
and cultured in normal DMEM.
The NP69, NP69 pLNSX, and NP69 pLNSX-LMP1 cells were
kindly provided by Dr. Sai-Wah Tsao of University of Hong Kong, PR
China. The establishment and characterization of the immortalized
nasopharyngeal epithelial cells NP69 have been previously described
[23,24]. Cells were cultured in keratinocyte-SFM (Invitrogen, Lyon,
France) supplemented with growth factor and bovine pituitary extract.
Transfection and Selection of Stable Clones
The PATAS cells were seeded at a density of 2 × 105 cells per 35-mm
plate 1 day before transfection. Transfections were performed with
Lipofectin (Invitrogen) according to the manufacturer’s instructions
using 2 μg of pBABE-puro-Ras-v12 or pBABE-hygro-hTERT (gift
from Dr. Robert A. Weinberg, Whitehead Institute for Biomedical Re-
search, Cambridge,MA) per plate. Vectors carrying only drug resistance
genes were used as controls. After selection with 2 μg/ml puromycin
or 100 μg/ml of hygromycin, respectively, antibiotic-resistant colonies
were recovered with stainless steel cloning cylinders (Bellco Glass, Inc,
Vineland, NJ) and continued to be cultured.
pZIP-Neo-SV(X), pBABE-puro, BARF1-expressing vector pZIP55
[19], or pBABE-puro-Ras-v12 was transfected into NP69 or NP69
pLNSX-LMP1 cells by the Lipofectin reagent as previously described.
pZIP55 and pBABE-puro-Ras-v12 were cotransfected into NP69 cells.
After selection with puromycin (0.8 μg/ml) for pBABE, 400 μg/ml
of G418 (Gibco, Lyon, France) for pZIP and pLNSX, the resistant
colonies were recovered with stainless steel cloning cylinders and con-
tinued to be cultured.
Detection of SV40 Large T, Small T, and BARF1 with
Polymerase Chain Reaction and Reverse Transcription–
Polymerase Chain Reaction in NP69 Cells
DNA and RNA were extracted from control and BARF1-expressing
NP69 cells with Trizol reagent (Invitrogen) according to the manufac-
turer’s instruction. Total RNA was treated with amplification-grade
Deoxyribonuclease I (Invitrogen). Reverse transcription–polymerase
chain reaction (RT-PCR) was carried out as previously described [25].
SV40 large T was amplified with primers 5′-CATCCTGATAAAG-
GAGGAGATG-3′ and 5′-CATGCTCCTTTAACCCACCT-3′.
SV40 small T was amplified with primers 5′-CATCCTGATAAAG-
GAGGAGATG-3′ and 5′-CGAAGCAGTAGCAATCAACC-3′. The
presence of theBARF1 transcripts in transfected cells was then examined
by PCR with specific primers for BARF1 (5′-AGGCTGTCACCG-
CTTTCTT-3′ and 5′-GGCTTCCTCCTTGTCATTTT-3′).
Telomerase Activity Assays
Telomerase activity in BARF1-transfected PATAS cells was mea-
sured using a protocol adapted from Intergen (TRAPeze Telomerase
Detection Kit). Three hundred nanograms of total cellular extract
was used in each telomerase activity assay. 293 cell extract was used
as a positive control. PCR cycling conditions were 94°C for 30 sec-
onds and 59°C for 30 seconds for 30 cycles. As a negative control,
every sample extract has been heat-inactivated at 85°C for 10 minutes
before assay.
Growth Rate Determination
For studies of growth capacity of PATAS cells, 1 × 105 cells of
PATAS, PATAS + BARF1 (P-BA), PATAS + BARF1 + Ras (P-BA-R),
PATAS + TERT (P-TE), and PATAS + TERT + Ras (P-TE-R) were
cultured in a 35-mm dish for 24 hours in DMEM supplemented with
10% serum. Cells were then trypsinized and centrifuged for 10 minutes
at 1000 rpm. Cell pellet was washed twice with serum-free DMEM.
A total of 0.1 × 105 cells were seeded in a 35-mm dish with 10%,
1%, or 0.2% serum in DMEM. Each cell line tested was plated in
triplicate. The culture medium was changed every 3 days with DMEM
containing 10%, 1%, or 0.2% of serum. Cells were trypsinized at the
seventh day, and the cell number was determined. For P-BA, P-BA-R,
P-TE, and P-TE-R, three subclones for each transfectant were also
tested in the same condition.
For studies of growth capacity of NP69 cells, control and BARF1-
expressing cells were seeded onto a 24-well plate (5 × 104 cells per
well). The cells were trypsinized, and viable cells were counted every
24 hours until 144 hours with Trypan blue exclusion assay. For
studies of growth factor dependence, 5 × 104 cells were cultured in
24-well plates for 24 hours in keratinocyte-SFM supplemented with
growth factor and bovine pituitary extract. Cells were then washed
twice with PBS and the medium was changed to keratinocyte-SFM
medium without growth factor and bovine pituitary extract. The
cells were observed daily and fed every 4 days until 13 days. Viability
was determined every 2 days by Trypan blue dye exclusion. Each
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time point was counted in triplicate. Growth curves were plotted
with means of each experiment, and error bars represented SEM.
Dense Focus Formation and Anchorage-Independent
Growth Assay
Focus formation assays were performed as described [26]. In brief,
we seeded 5 × 105 cells per well of a six-well plate in DMEM sup-
plemented with 10% of serum for PATAS cells and in keratinocyte-
SFM supplemented with growth factor and bovine pituitary extract
for NP69 cells and incubated them for 2 weeks with medium
changes twice per week.
The anchorage-independent growth ability of the BARF1-expressing
PATAS and NP69 cells was examined by soft agar colony assay as de-
scribed [18]. Cells were suspended in 0.35% agarose (Seaplaque, FMC
Bioproducts, Rockland,ME) and then added on top of a base-solidified
base layer of 0.6% agarose at a density of 3 × 103 cells per well of a six-
well plate. Each cell line tested was plated in triplicate. Cultures were fed
once a week with two to three drops of medium. The cell colonies be-
came visible microscopically after 1 week, and after 2 weeks, each cell
population was photographed with a Nikon phase-contrast microscope
(Nikon, Lyon, France) equipped with a camera.
Tumorigenicity Assay
As previously described [18], PATAS and NP69 cells were grown in
log-phase for 24 hours. Then, cells were harvested, counted, and
washed twice with serum-free medium. A total of 10 × 106 cells for each
cell line were injected subcutaneously into nude mice with Matrigel.
Equal volumes of serum-free DMEM with Matrigel were injected as
a negative control. The mice were then examined weekly and observed
for approximately 3 months for any sign of tumorigenic growth.
Immunofluorescence Analysis of Keratin in Tumors
Primary PATAS cells, PT8 cell line, tumor cells cultured after 4 days
(TL1), and 30th passage were cultured in microchamber for 72 hours
and fixed with acetone for 15 minutes, then anti–AE1/AE3 with a
dilution of 50 was treated on each cells.
Western Blot Analysis
Immunoblot analysis was performed as previously described [18];
after separation by 8% to 12% polyacrylamide gel electrophoresis, the
following antibodies were used to confirm protein expression: primary
antibody against Bcl-2 (sc-7382; Santa Cruz, Germany), c-myc (sc-764;
Santa Cruz), BARF1 (anti–Pep 2A serum, a polyclonal rabbit antiserum
prepared against a synthetic peptide corresponding to a presumed epi-
tope, amino acids (aa) 172 to 180 [NGGVMKEKD], of the BARF1
protein), Ras (sc-29; Santa Cruz), SV40 Tantigen (sc-148; Santa Cruz;
N-terminal epitope mapping within residues 1 to 82 of SV40 large
T antigen for detection of 94-kDa SV40 LT antigen and 21-kDa SV40
ST antigen), LMP1 (BD Biosciences Pharmingen, San Diego, CA),
h-TERT (SC-7212; Santa-Cruz), and tubulin (sc-5286; Santa Cruz).
Results
BARF1 Induced the Activation of Telomerase in
Immortalized PATAS
To become immortalized, human cells must bypass two barriers:
replicative senescence and crisis. Replicative senescence can be avoided
by the expression of SV40 large Tantigen (LT) in presenescent human
cells [27,28]. Crisis can be averted by additional expression of the telo-
merase catalytic subunit (hTERT), thereby yielding immortalized cells
[29,30].Our previouswork showed that introduction of theBARF1 gene
could immortalize PATAS cells, which are primary kidney epithelial cells
derived from the monkey Erythrocebus patas and which senesced after
about three passages in DMEM containing 10% fetal calf serum [22].
We therefore asked whether the BARF1-induced immortalization of
PATAS cells was due to the activation of telomerase. As illustrated in
Figure 1A, in BARF1-transfected PATAS cell populations, strong telo-
merase activity was detected by telomeric repeats amplification protocol
(TRAP) as early as the sixth passage (Ba 6). However, no telomerase
activity was observed in primary cells transfected with the control vec-
tor at the same passage (Ve 6). Consistent with these results, a weak ex-
pression of TERT proteinwas detected at sixth passage and becamemore
evident by 10th passage (Figure 1B, lanes 2 and 3). By the 30th pas-
sage, BARF1-transfected cell populations exhibited a similar intensity
of TERT band (Figure 1B, lane 4) to cells transfected with hTERT gene
(Figure 1B, lanes 5-7 ). Interestingly, the increased TERT activity in
BARF1-transfected cells was accompanied by a parallel up-regulation
of BARF1 and c-myc expression (Figure 1C ). Moreover, by cotransfec-
tion of different hTERT promoter-luciferase reporter vectors together
with BARF1-expressing vector into PATAS and HeLa cells, we con-
firmed that BARF1 could directly induce telomerase activation by target-
ing initiator (Inr) elements at positions +13 and +43 in hTERTpromoter
region (data not shown). To determine whether elevated telomerase
expression alone suffices to immortalize primary PATAS epithelial cells,
we transfected hTERT-expressing vector into primary PATAS cells and
followed the growth kinetics of the resulting cells every 3 or 4 days for
5 months. As shown in Figure 1D, hTERT-transfected cells exhibited
constant exponential growth during this period, whereas empty vector–
transfected control cells underwent senescence within 36 days (approxi-
mately six passages). Notably, hTERT-transfected clones showed similar
growth rate to BARF1-transfected cell clones in vitro (Figure 1E). This
observation suggested BARF1 induced immortalization of PATAS cells
might be mediated by telomerase activation.
BARF1 Could Induce Malignant Transformation by
Cooperating with a Limited Number of Oncogenes
Previous studies revealed that in combination with EBV latent infec-
tion, the collaborative disruption of RB, p53, c-myc, Bcl-2, and Ras
pathways and telomerase activity may be involved in the pathogenesis
of NPC [9,31,32]. Our previous data indicated that pro-oncogenes of
the Ras family (K-Ras and H-Ras) were activated in NPC tumor epi-
thelial cells [33]. Therefore, we introduced H-Ras oncogene (mutated
in valine to glycine at codon 12) into BARF1- or hTERT-immortalized
PATAS cells as well as BARF1- or LMP1-transfected NP69 cells to in-
vestigate whether the cooperation of these different oncogenes could
induce malignant transformation.
We first examined the cooperative effect of these oncogenes on
focus formation ability. No H-Ras expression was detected in either
primary PATAS cells or hTERT-immortalized cells (P-TE), but BARF1-
immortalized (P-BA) cells had slightly increased expression of H-Ras.
H-Ras expression was much higher in H-Ras–transfected P-BA cells
(P-BA-R) and H-Ras–transfected P-TE (P-TE-R; Figure 2A). Consis-
tent with our previous results [18], elevation of c-myc and Bcl-2 ex-
pression was also detected in BARF1-expressing cells. These cell lines
were cultured for 2 weeks after confluence without passage to assess
focus formation ability. Surprisingly, P-BA-R but not P-TE-R cells
lost their contact inhibition and displayed a large number of foci
(Figure 2B, b and d ). As expected, no such foci were observed in
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primary cells, P-BA cells (Figure 2B, a and c), or P-TE cells (data
not shown). In addition, primary cells expressing H-Ras could not be
passaged because they entered a senescent state within few population
doublings after transfection.
Next, we examined the effect of BARF1 in NP69 cells by focus
formation assay. NP69 cell line is an immortalized human nasopharyn-
geal epithelial cell line that cannot proliferate in soft agar or induce
tumor formation in immunocompromised mice [23,34]. In addition
to NP69 vector (pLNSX) and NP69-LMP1 (pLNSX-LMP1) cells
(from Dr. Sai-Wah Tsao), we established different monoclonal cells in-
cluding NP69 vector (pZIP-Neo-SV(X)), NP69 vector (pBABE-puro),
NP69–H-Ras (pBABE-puro-Ras-v12), NP69-BARF1 (pZIP55 [19]),
NP69–BARF1 + H-Ras, and NP69–LMP1 + H-Ras. Because we ob-
served no differences in cell growth rate, focus formation or soft agar
colony formation among NP69–pZIP-Neo-SV(X), NP69–pBABE-
puro, or NP69–pLNSX cells, we chose NP69–pZIP-Neo-SV(X) cells
Figure 1. (A) Telomerase activity in BARF1-transfected PATAS cells. 293 cell extract was used as a positive control, and PATAS cell trans-
fected with empty vector (Ve) was used as a negative control. Cell extracts from 6th, 10th, and 30th passages after BARF1 transfection (Ba)
were tested for telomerase activity by using the PCR-based TRAP assay. Heat-inactivated (HI) sampleswere included as controls. IC refers to
an internal PCR standard to demonstrate the absence of PCR inhibitors in the cellular extracts. (B) Detection of TERT expression in PATAS
cell immortalization by BARF1. Protein was extracted from the indicated passage after BARF1 transfection, and TERT expression was
analyzed byWestern blot. (C) Expression ofBARF1 and c-myc byWestern blot analysis in PATAS cells transfectedwithBARF1 (Ba) or control
vector (Ve). Actin protein was used to confirm even loading. (D) Expression of hTERT immortalizes primary PATAS cells. Cells were trans-
fected with a control vector expressing a drug resistance marker alone or with hTERT gene. Cell proliferation (Population doublings) was
measured during 150 days. Cells lacking hTERT (♦) entered crisis and could no longer be passaged. Squares (□) indicate cells expressing
hTERT. (E) Comparative study on cell growth between BARF1- and hTERT-transfected PATAS cells. Cells were seeded at a 35-mm plate
in DMEM supplemented with 10% serum. Cell number was monitored daily to assess growth rate. Each experiment was performed in
triplicate, and results represented the mean ± SD of three experiments.
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to represent empty vector control cells. Previous studies reported that
the NP69 cell line was immortalized only by the SV40 large T antigen
[23]. However, we noted that the vector that was used to establish NP69
cell line might have been constructed from the SV40 genome DNA
fragment, so we doubted that SV40 early region (ER) was introduced.
The SV40 ER encodes three distinct proteins by alternative splicing, in-
cluding the 708-aa large Tantigen, the 174-aa small Tantigen (ST), and
the 135-aa 17K T antigen (Figure 2C) [35,36]. Both LT and ST have
been intensively studied not only because they play important roles in
viral transcription and replication but also because they participate in cell
immortalization and transformation [37]. Therefore, we designed two
pairs of primers to test the possible existence of ST. One spanned the
346-bp intron and was located in LTexons 1 and 2 to confirm the exis-
tence of the intron (Figure 2C), and the other one was located in LTexon
1 and intron (both of them in the CDS region of ST) to detect the
transcript of ST. As shown in Figure 2D, we found that the transcripts
of both LTand STexisted in NP69 cells. Furthermore, by immunoblot
analysis, we also detected that both LT and ST proteins were expressed
in NP69 cells (Figure 4,C andD). These observations indicated that the
NP69 cell line was immortalized by at least SV40 LT and ST.
Within transfected NP69 cells, we also observed that NP69-BARF1
and NP69–BARF1 + Ras cells continued to proliferate to form foci on
the surface of monolayer cells, but no obvious foci were detected in the
other cells. However, compared with NP69-BARF1 cells, there were
denser, larger, and more foci in NP69–BARF1 + Ras cells. Because most
of the NP69-LMP1 cells peeled off the dish surface during the long-
time culture without passage, we could not observe any foci formation
at the same time point.
Next, we analyzed the cooperative effects of different oncogenes on
cell growth capacity. PATAS cells were evaluated by culturing differently
transformed PATAS cells in DMEM supplemented with 10%, 1%, or
0.2% of serum. As shown in Figure 3A, primary PATAS cells grew
slowly in culture medium with 10% serum and almost could not grow
with 1% or 0.2% serum, whereas P-BA, P-TE, and P-TE-R cells could
proliferate consistently with 10% or 1% serum. However, when these
clonal cells were cultured with 0.2% serum, they could only grow no
more than 3 days. Only P-BA-R cells could proliferate in all three
serum concentrations and grew in a much higher rate than other trans-
fectants with 10% and 1% serum. These results showed that the intro-
duction of H-Ras gene rendered serum-independent growth advantage
to BARF1-immortalized PATAS cells but not to hTERT-immortalized
PATAS cells in low serum conditions.
The cooperative effects of different oncogenes on NP69 cell growth
were assessed by comparison of growth curve and growth factor depen-
dence among different cells populations. As seen in Figure 3B, the ad-
ditional coexpression of BARF1 and H-Ras (in BARF1 + Ras NP69
cells) had a significant effect on the rate of proliferation, which resulted
in a doubling time 20% shorter than that of empty vector control cells.
Other cell lines grew in a similar way to the empty vector control cells.
After 6 days, the maximum cell number of BARF1 + Ras, BARF1, and
Figure 2. (A) Detection of H-Ras, c-myc, and Bcl-2 by Western blot analysis in primary PATAS cells, BARF1-transfected PATAS (P-BA),
BARF1 and Ras–transfected PATAS (P-BA-R), hTERT-transfected PATAS (P-TE), and hTERT and Ras–transfected PATAS cells (P-TE-R).
(B) Foci formation was detected by light microscopy. Whereas BARF1-transfected PATAS cells showed an organized growth (photo-
graphed at ×50 [a] and ×100 [c]), PATAS expressing both BARF1 and Ras genes formed a higher number of large foci (photographed
at ×50 [b] and ×100 [d]). Cells were cultured in DMEM supplemented with 10% serum. (C) Schematic diagram of the SV40 ER and
the alternatively spliced SV40 viral transcripts coding for large T, small T, and 17K T proteins. Numbering refers to the SV40 genomic
nucleotide numbers. Origin of replication was indicated as Ori. (D) PCR for the detection of the alternatively spliced messenger RNA
encoding the SV40 ST. Positions of PCR primers are indicated in panel A. m, marker. a, PCR with NP69 cell DNA to amplify SV40 ER
including LT exons and intron. b, RT-PCR with NP69 cell RNA to amplify SV40 LT transcript. c, RT-PCR with NP69 cell RNA to amplify
SV40 ST transcript. d, RT-PCR with 293T cell RNA to amplify SV40 LT transcript. e, PCR with 293 cell DNA as negative control.
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Figure 3. (A) BARF1 and Ras rendered PATAS cells resistant to serum deprivation. Cells were seeded at 0.1 × 105 cells per 35-mm plate in
DMEM supplemented with 10% serum. After 24 hours, cultured were washed twice with serum-free medium then incubated with DMEM
supplemented with 10%, 1%, and 0.2% serum for 7 days. Viable cells were counted by Trypan blue staining on day 7. Each cell line tested
was plated in triplicate. a, Primary PATAS cells (PATAS). b, hTERT-immortalized PATAS cells (P-TE). c, BARF1-immortalized PATAS cells
(P-BA). d, Ras-transfected P-BA cells (P-BA-R). e, Ras-transfected P-TE cells (P-TE-R). (B) Growth curves of BARF1-expressing NP69 cells
and control cells that were cultured in medium with growth factors and bovine pituitary extract. Each experiment was performed in tripli-
cate, and results represented the mean ± SD of three experiments. (C) Growth curves of BARF1-expressing NP69 cells and control cells
in medium without growth factors and bovine pituitary extract. Each experiment was performed in triplicate, and results represented the
mean ± SD of three experiments: NP69 vector (filled squares), NP69-BARF1 (open triangles), NP69–BARF1 + Ras (filled triangles), NP69-
LMP1 (open diamonds), NP69–LMP1+ Ras (filled diamonds), and NP69-Ras (open squares). (D) Soft agar colony formation assays. a, hTERT-
immortalized PATAS cells (P-TE). b, BARF1-immortalized PATAS cells (P-BA). c, Ras-transfected P-BA cells (P-BA-R). d, Ras-transfected P-TE
cells (P-TE-R). The colonies were photographed after 2 weeks. (E) Photomicrographs of anchorage independent growth in soft agar. a, NP69
vector cells. b, NP69-Ras cells. c, NP69-LMP1 cells. d, NP69–LMP1 + Ras cells. e, NP69-BARF1 cells. f, NP69–BARF1 + Ras cells. Original
magnifications: a1, b1, c1, d1, and e1, ×50; for a2, b2, c2, d2, and e2, ×100. All the colonies were photographed after 2 weeks.
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empty vector control cells was 4.8 ± 0.27 × 105, 4.0 ± 0.20 × 105, and
3.2 ± 0.05 × 105, respectively. Morphologic differences were found
among the BARF1 cells and other cells; BARF1 cells were round or
in oviform shape and in larger size in comparison with the empty vector
control NP69 cells. LMP1-expressed NP69 cells exhibited an elongated
fibroblastlike shape as previously reported [34], whereas H-Ras–only
introduced NP69 cells exhibited no morphologic difference from the
empty vector control NP69 cells.
To examine the growth factor dependence of different NP69 cells
(Figure 3C), growth factor and bovine pituitary extract were withdrawn
from culture medium. As expected, BARF1-expressing cells (BARF1 +
Ras NP69 cells and BARF1 NP69 cells) were more resistant to growth
factor deprivation, and their proliferation could still be detected at day 12.
In contrast, all other cells, especially NP69-LMP1 cells, underwent
growth arrest by day 7, with a marked decrease in cell number. Under
the culture condition without growth factor and bovine pituitary extract,
we noticed that the NP69–LMP1 + Ras cells could proliferate and spread
across the surface of the dish until the entire surface was covered with a
monolayer of cells, but the NP69-LMP1 cells grew in a scattered pat-
tern with a marked reduction in cell-cell contact. After confluence, all
cell populations except NP69-LMP1 cells could be kept for more than
4 weeks by only changing the medium without passage, but the NP69-
LMP1 cells would peel off, and the number of attached cells significantly
decreased from approximately the 10th day. In addition, the NP69-
LMP1 cells seemed to be more sensitive to trypsinization than the others.
These observations are consistent with previous reports that high levels
of LMP1 expression might be toxic to some cell lines, including several
human B-lymphoid cell lines (Raji, GG68, BL60, etc.), BALB/3T3,
143/EBNA1, HEp-2 cells [38,39], and CNE2 cells [40]. Although the
precise mechanisms of LMP1-induced inhibition of cell proliferation are
not clear, we found that the introduction ofH-Ras into LMP1- expressing
NP69 cells could partially overcome this inhibition and conferred these
cells with an increased resistance to the toxicity.
We then examined the anchorage-independent growth properties of
transfected PATAS and NP69 cells in soft agar. For PATAS cells, we
only observed colony formation in BARF1 and H-Ras coexpressed
PATAS cell clones (P-BA-R; Figure 3D, c). Within NP69 cells, the
colonies formed by NP69–BARF1 + Ras (Figure 3E , f1 and f2) cells
were larger in size and becamemicroscopically visible 3 days earlier than
those formed by NP69-BARF1 (Figure 3E , e1 and e2), NP69-LMP1
(Figure 3E , c1 and c2), and NP69–LMP1 + Ras cells (Figure 3E , d1
and d2). Probably because of the LMP1 expression-induced toxicity
Figure 4. (A) Expression of BARF1 protein and H-Ras in cell lines, tumor biopsies, and tumor cell lines. Cell extracts were prepared from
PATAS (primary cells), P-BA (PATAS transfected by BARF1), P-BA-R (P-BA plus Ras), P-BA-R-T (tumor biopsy induced by injection of P-BA-R),
and P-BA-R-TL (established cell line from tumor biopsy induced by injection of P-BA-R). For BARF1 detection, A20, BARF1 protein produced
by BARF1 recombinant adenovirus systemwas used as a positive control. For H-Ras detection, we used protein extracted from NPC biopsy
expressing a high Ras protein (NPC26) as a positive control. (B) Detection of cytokeratin AE1/AE3 in cell lines. Cells were cultured in micro-
chamber for 72 hours and fixed with acetone for 15 minutes, then anti–AE1/AE3 with a dilution of 50 was treated on each cell. a, Primary
PATAS cells. b, P-BA-R cell line. c, P-BA-R tumor cell culture after 4 days (TL1). d, The 30th passage of P-BA-R tumor cell line (TL1).
(C) Western blot analysis of associated signaling molecules in BARF1-expressing, LMP1-expressing, and control cell populations. Different
cell populations were indicated at the top of the panel. The detected proteins are indicated on the right side. (D) RT-PCR detection of BARF1
andWestern blot analysis of Ras and SV40 LT and ST expressions in cloned cell line and tumors. Different tumors formed by NP69–BARF1+
Ras cloned cell line were indicated at the top of the panel. The detected molecules are indicated on the right side.
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that we described previously, the cells in the LMP1-expressing clones
underwent apoptosis after approximately 10 days (Figure 3E , c1, c2,
d1, and d2). No colonies formed within 3 weeks by the NP69 vector
(Figure 3E , a1 and a2) or NP69-Ras (Figure 3E , b1 and b2) cells in
three independent experiments (Table 1).
Cooperation of BARF1 and Other Oncogenes Conferred
Tumorigenicity in Nude Mice
Finally, we investigated the cooperative effect of different oncogenes
on the tumorigenic properties of various PATAS and NP69 cells in
nude mice. HeLa cells, as a positive control, readily formed tumors
in this assay, although no tumors were observed in PATAS cells ex-
pressing BARF1, hTERT, or hTERT and H-Ras after a 1-month obser-
vation. In marked contrast, when PATAS cells expressing BARF1 and
H-Ras were introduced, rapidly growing tumors were observed as early
as 1 week (Table 1). These data suggest that, together, expression of
BARF1 and H-Ras is sufficient to induce the transformation of pri-
mary epithelial PATAS cells. No tumor was observed in NP69 vector,
NP69-Ras, NP69-LMP1 [34], NP69-BARF1, or NP69–LMP1 + Ras
cells after 2 months as expected. However, injection of HeLa cells
or NP69 cells coexpressing BARF1 and H-Ras induced progressively
enlarged tumors at the sites of inoculation (Table 1).
To ensure that tumors developed in nude mice were transfected cells
in origin, the expression ofH-Ras,BARF1, SV40Tantigens, and keratin
was analyzed. As illustrated in PATAS cells in Figure 4A, the expression
of BARF1 and H-Ras protein was present in all cases: before injection
(P-BA-Ras-2), tumor (P-BA-Ras-2-T, P-BA-Ras-3-Tand P-BA-Ras-4-T),
and established cell line from tumor biopsy induced by injection of
P-BA-Ras (P-BA-R-TL1 and P-BA-R-TL2). To verify whether the
established cell lines from the tumor biopsy were of epithelial origin,
immunofluorescence with monoclonal anti–AE1/AE3 was performed
[22]. In the detection of keratin expression, PATAS primary cells exhib-
ited a low level of expression of AE1/AE3 keratin (Figure 4B, a), and
enhanced expression was detected in BARF1-transfected PATAS cells
(Figure 4B, b), BARF1/Ras–transfected PATAS cells (data not shown),
and tumor cells (Figure 4B, c and d ).
As shown in Figure 4C , upregulated expression of c-myc and Bcl-2
was detected in the NP69 cells when BARF1 or LMP1 was introduced.
As to tumor formed by transfected NP69 cells, the expressions of
BARF1, Ras, and SV40 T antigens (Figure 4D) were confirmed.
Discussion
NPC represents a superb model of gene-environment-virus inter-
action in the pathogenesis of cancer [25]. Previous studies revealed that,
in combination with EBV infection, multiple genetic and epigenetic
alterations accumulate, including p53 inactivation by either overexpres-
sion of ΔN-p63 or loss of p14/ARF [9,31], mutations in RB2/p130
gene [41] or constitutional RB phosphorylation resulting from loss of
p16 [42]. Aberrant expression and point mutation of the Ras gene,
up-regulation of Bcl-2 [43] and c-myc [44–46], as well as increased telo-
merase activity [32] have also been shown to be involved in the devel-
opment of NPC, thereby indicating that EBV infection and cumulative
genetic alterations are critical events for the deregulation of cell prolif-
eration in NPC cells.
Although elucidation of the mechanism of NPC pathogenesis is dif-
ficult, such investigations are important not only for understanding
the mechanisms of tumorigenesis but also for finding methods for
cancer prevention and development of more effective anticancer drugs.
Table 1. Colony Formation in Soft Agar and Tumor Formation in Nude Mice.
Cell Lines Injected Genotype Colony Formation Tumors/Injection Sites Tumor Size (cm)
Day 14 Day 28
HeLa 4/4 1.3 × 1.6 2.7 × 3.4
PATAS 0 0/4 0 0
P-BA–clone 1 BARF1+, hTERT−, Ras− 0 0/4 0 0
P-BA–clone 3 BARF1+, hTERT−, Ras− 0 0/4 0 0
P-BA-R–clone 2 BARF1+, hTERT−, Ras+ 42 4/4 0.8 × 1.2 1.4 × 2.3
P-BA-R–clone 3 BARF1+, hTERT−, Ras+ 36 4/4 0.7 × 1.0 1.1 × 2.4
P-BA-R–clone 5 BARF1+, hTERT−, Ras+ 46 4/4 0.9 × 1.3 1.7 × 2.7
P-TE–clone 1 BARF1−, hTERT+, Ras− 0 0/4 0 0
P-TE–clone 2 BARF1−, hTERT+, Ras− 0 0/4 0 0
P-TE–clone 3 BARF1−, hTERT+, Ras− 0 0/4 0 0
P-TE-R–clone 1 BARF1−, hTERT+, Ras+ 0 0/4 0 0
P-TE-R–clone 3 BARF1−, hTERT+, Ras+ 0 0/4 0 0
P-TE-R–clone 7 BARF1−, hTERT+, Ras+ 0 0/4 0 0
NP69 vector BARF1−, SV40 LT/ST+, Ras− 0 0/4 0 0
NP69-LMP1 BARF1−, SV40 LT/ST+, Ras−, LMP1+ 0 0/4 0 0
NP69-Ras–clone 1 BARF1−, SV40 LT/ST+, Ras+ 0 0/4 0 0
NP69-Ras–clone 2 BARF1−, SV40 LT/ST+, Ras+ 0 0/4 0 0
NP69-BARF1–clone 2 BARF1+, SV40 LT/ST+, Ras− 0* 0/4 0 0
NP69-BARF1–clone 3 BARF1+, SV40 LT/ST+, Ras− 0* 0/4 0 0
NP69-BARF1–clone 4 BARF1+, SV40 LT/ST+, Ras− 0* 0/4 0 0
NP69–LMP1 + Ras–clone 1 BARF1−, SV40 LT/ST+, Ras+, LMP1+ 0 0/4 0 0
NP69–LMP1 + Ras–clone 2 BARF1−, SV40 LT/ST+, Ras+, LMP1+ 0 0/4 0 0
NP69–LMP1 + Ras–clone 3 BARF1−, SV40 LT/ST+, Ras+, LMP1+ 0 0/4 0 0
NP69–BARF1 + Ras–clone 1 BARF1+, SV40 LT/ST+, Ras+, LMP1− 38 4/4 0.4 × 0.9 0.9 × 1.8
NP69–BARF1 + Ras–clone 2 BARF1+, SV40 LT/ST+, Ras+, LMP1− 41 4/4 0.6 × 0.8 1.0 × 1.7
NP69–BARF1 + Ras–clone 3 BARF1+, SV40 LT/ST+, Ras+, LMP1− 43 4/4 0.9 × 1.1 1.2 × 1.9
For colony formation, data shown here are the mean values of the measurements from triplicate wells. The number of colonies of 100 cells or more formed in each well was counted under a phase-
contrast microscope.
For tumor formation, 107 cells for each cell line were injected subcutaneously into nude mice with Matrigel. Equal volumes of serum-free DMEM with Matrigel were injected as a negative control. The
size of tumor in centimeters is the mean of four tumors for each cell line and clone.
*Observed some colonies containing 10 to 30 cells per heap in wells.
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Previous attempts have established several NPC epithelial cell lines,
such as HONE1 [47,48], CNE1, CNE2, and C666 [49], from
NPC biopsy tissues. Seto et al. [50,51] generated BARF1-rEBV carry-
ing the BARF1 gene under the SV40 promoter using an Akata cell
system and established BARF1-rEBV–infected HONE-1 and CNE-1
cell NPC cell clones and then produced tumors in nude mice. How-
ever, such cell lines already contained chromosomal abnormalities, and
thus, their genetic constitution remains obscure. Therefore, the devel-
opment of a suitable model system with which to study the viral and
genetic events underlying the malignant transformation of human naso-
pharyngeal epithelial cells is critical.
By introducing the BARF1 gene, we established immortalized primate
epithelial PATAS cells that could proliferate more than 100 passages
and grow in highly diluted culture condition in vitro, but no tumors
were induced after the injection in nude mice. In addition, an SV40 T
antigens–immortalized human nasopharyngeal epithelial cell line,NP69,
was established recently [23]. Therefore, the establishment of BARF1-
immortalized PATAS cells and SV40 T antigens–immortalized NP69
cell line did provide a valuable experimental model to investigate the role
of BARF1 in tumorigenesis of NPC.
Previous studies, including our own, demonstrated that immortali-
zation is necessary but not sufficient for malignant transformation. This
notion was exemplified by the studies of Hahn et al. [35,52] and
Elenbaas et al. [53] who demonstrated that human fibroblasts and epi-
thelial cells could be immortalized by SV40 LT plus hTERT and be
transformed to a tumorigenic state by ectopic expression of an activated
form of the RasV12G oncogene, hTERT, and SV40 T (LTand ST) anti-
gens. Interestingly, here we showed that BARF1-immortalized PATAS
cells grew continuously in the same manner as hTERT-immortalized
cells during 150 days in vitro, but no tumors formed in nude mice.
In contrast, malignant transformation of PATAS cells was induced by
the additional transfection of H-Ras gene into BARF1-immortalized
PATAS cells but not to hTERT-immortalized cells. The observation
suggested that not only telomerase activation but also some other signal
pathways, including c-myc, have been altered in the immortalization
and transformation of PATAS cells by BARF1. In comparison with
the data obtained by Hahn et al. and Elenbaas et al., primary primate
epithelial PATAS cells were immortalized by BARF1 and malignantly
transformed by introduction of BARF1 and H-Ras. The discrepancy
might have resulted from different cell types (different species and tissue
origin) used or unknown gene alteration.
In addition, we introduced BARF1 and H-RasV12G oncogenes into
SV40 T antigens–immortalized NP69 cells and established the co-
operation of BARF1, H-Ras, SV40 small and large T antigens in this
immortalized cells, thus for the first time driving tumorigenesis in non-
malignant human nasopharyngeal epithelial cells. We presume that
in this system, SV40 LT simultaneously disables the tumor suppressor
p53 and RB proteins to release cells from growth arrest and apoptosis
[37,54], whereas SV40 ST inhibits the activity of phosphatase 2A
[35,55–57] and H-RasV12G activation facilitates cellular proliferation,
transformation, angiogenesis, invasion, and metastasis [58,59]. Com-
bined with these effects, the introduction of BARF1 oncogene perturbs
several pathways, including c-myc [21] and Bcl-2 [18] pathways, and
activates telomerase to permit indefinite replication of cells. Ultimately,
the collective and cooperative interaction of these genes might confer
the malignant transformation to NP69 cells. Therefore, our results
suggested that in NPC carcinogenesis, EBV-encoded BARF1 over-
expression cooperates with the disruption of a number of cellular path-
ways, including inactivation of tumor suppressors p53 and RB,
overexpression of oncogene H-RasV12G, and activation of hTERT. In
addition, all these effects may induce human nasopharyngeal epithelial
cell into malignancy. Meanwhile, we found that elevated expression of
c-myc and Bcl-2 was detected not only in BARF1-expressing cell lines
but also in hTERT- and H-Ras–expressing cell lines, and in LMP1-
andH-Ras–expressing cell lines when compared with the vector control;
however, increased colony formation was only observed in BARF1- and
BARF1 + Ras–expressing cells, whereas only BARF1 + Ras–expressing
cells can form tumors in nude mice. Deregulation of c-myc and/or
BCL-2 expression, therefore, cannot be the main mechanism of cell
transformation by BARF1. Some other signaling pathway might have
been disrupted and played an important role in the transformation
process. Further investigation with the established models may help to
elucidate the underlying mechanism.
This study provides a blueprint of the genetic and viral events that
could lead to NPC development and permits identification of other
oncogenic signals needed to transform normal nasopharyngeal epithelial
cells, particularly these mimicked by the introduction of equivalent to
SV40 T antigens and BARF1. In conclusion, this establishes an ideal
basis for the testing of novel preventive or therapeutic approaches in
the treatment of NPC.
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